Otsuka eyeing Claris' IV infusions business amid wider business factors
This article was originally published in Scrip
Executive Summary
Otsuka Holdings is in negotiations for a possible acquisition of the intravenous infusions business of India's Claris Lifesciences, Scrip understands, in a development that reflects broader issues across both firms' pharmaceutical-led businesses.